DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.52+0.48 (+0.59%)
Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –
DexCom market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
DexCom's market cap was $30.32B on Nov 11, 2026, against $24.75B a year earlier. Over the last 5 years it ranged from $22.83B to $53.45B, with a median of $33.92B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $30.32B | +17.1% |
| 2025 | Dec 31, 2025 | $25.88B | -14.8% |
| 2024 | Dec 31, 2024 | $30.38B | -36.6% |
| 2023 | Dec 29, 2023 | $47.95B | +9.6% |
| 2022 | Dec 30, 2022 | $43.73B | -15.9% |
| 2021 | Dec 31, 2021 | $52.03B | +46.6% |
| 2020 | Dec 31, 2020 | $35.49B | +77.3% |
| 2019 | Dec 31, 2019 | $20.01B | +88.1% |
| 2018 | Dec 31, 2018 | $10.64B | +113.3% |
| 2017 | Dec 29, 2017 | $4.99B | -1.1% |
| 2016 | Dec 30, 2016 | $5.04B | -24.2% |
| 2015 | Dec 31, 2015 | $6.66B | +58.3% |
| 2014 | Dec 31, 2014 | $4.21B | +65.7% |
| 2013 | Dec 31, 2013 | $2.54B | +169.8% |
| 2012 | Dec 31, 2012 | $941.11M | +49.8% |
| 2011 | Dec 30, 2011 | $628.43M | – |
See a number that looks wrong?